Loading…
Drugs Made In America Acquisition II Corp. is projected to rise to $12.31 by 2027, a +22% move from its current price of $10.11. DMII is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $10.09 | $10.11 | $10.14 | +0.03% |
| Aug 3 | $10.08 | $10.12 | $10.15 | +0.06% |
| Aug 4 | $10.07 | $10.12 | $10.17 | +0.09% |
| Aug 5 | $10.07 | $10.12 | $10.18 | +0.12% |
| Aug 6 | $10.07 | $10.13 | $10.18 | +0.15% |
| Aug 7 | $10.06 | $10.13 | $10.19 | +0.18% |
| Aug 8 | $10.06 | $10.13 | $10.20 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.06 | $10.13 | $10.20 | +0.21% |
| Week 2 | $10.05 | $10.15 | $10.25 | +0.43% |
| Week 3 | $10.05 | $10.17 | $10.30 | +0.64% |
| Week 4 | $10.06 | $10.20 | $10.34 | +0.85% |
| Week 5 | $10.06 | $10.22 | $10.38 | +1.07% |
| Week 6 | $10.07 | $10.24 | $10.41 | +1.28% |
| Week 7 | $10.08 | $10.26 | $10.45 | +1.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Drugs Made In America Acquisition II Corp. is a financial services company that does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Drugs Made In America Acquisition II Corp. (DMII) is currently priced at $10.09 per share and has a market capitalization of $642.73M. It is ranked 2782 in market cap among listed assets. The asset is categorized within Financial Services.
A major floor 1.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.6% away) — a key level to hold.
Price is pressing into resistance (0.1% away) — a breakout level to watch.
A major ceiling 0.5% above — clearing it would confirm fresh momentum.
Key DMII support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DMII market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.11 | Sell | $10.11 | Sell |
| MA 10 | $10.10 | Buy | $10.10 | Buy |
| MA 20 | $10.10 | Buy | $10.10 | Buy |
| MA 50 | $10.08 | Buy | $10.08 | Buy |
| MA 100 | $10.04 | Buy | $10.05 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.53 | Neutral |
| Stoch RSI (14) | 60.47 | Neutral |
| CCI (20) | 93.72 | Neutral |
| Williams %R (14) | -25.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.30 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 75.00 | Neutral |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 67.41 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 10.12 | Sell |
| ADX (14) | 18.45 | Neutral |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is bullish, with RSI14 at 50 and the 50-day simple moving average at $10.07.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.88 | $10.11 | $13.74 | 0% | Neutral | |
| $9.78 | $12.31 | $16.39 | +22% | Bullish | |
| $10.19 | $13.20 | $18.27 | +31% | Bullish | |
| $10.45 | $13.87 | $19.79 | +37% | Bullish | |
| $11.65 | $15.79 | $23.10 | +56% | Bullish | |
| $13.05 | $18.04 | $26.97 | +78% | Bullish | |
| $15.10 | $21.25 | $32.41 | +110% | Bullish | |
| $16.80 | $24.05 | $37.34 | +138% | Bullish | |
| $17.04 | $24.79 | $39.12 | +145% | Bullish | |
| $18.33 | $27.10 | $43.41 | +168% | Bullish | |
| $26.02 | $41.26 | $70.43 | +308% | Bullish | |
| $42.28 | $75.70 | $141.69 | +649% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $9.88 | $10.11 | $12.32 | +0.00% |
| September 2026 | $8.83 | $10.46 | $12.74 | +3.42% |
| October 2026 | $8.71 | $10.39 | $12.81 | -0.59% |
| November 2026 | $8.75 | $10.49 | $13.04 | +0.95% |
| December 2026 | $9.09 | $10.96 | $13.74 | +4.47% |
Click any year to see its month-by-month DMII forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect DMII to range from $9.88 to $13.74 through 2026. The $10.11 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The DMII price prediction for 2027 points to an average of $12.31 (low $9.78, high $16.39) — a potential gain of +22% on today's $10.11. Buyers look set to stay in control over this stretch.
In 2028, DMII is projected to trade between $10.19 and $18.27, averaging $13.20 — a potential gain of +31% from today's $10.11. That is up +7% on the projected 2027 average. Momentum favours further upside here.
Drugs Made In America Acquisition II Corp.'s 2029 outlook centres on $13.87, within a $10.45 to $19.79 range. That is up +5% on the projected 2028 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, DMII could reach as high as $23.10, with a base case around $15.79 and support toward $11.65 — roughly +56% from $10.11. Momentum favours further upside here.
Expect DMII to range from $13.05 to $26.97 through 2031. The $18.04 average target implies a +78% move from current prices. That is up +14% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The DMII price prediction for 2032 points to an average of $21.25 (low $15.10, high $32.41) — a potential gain of +110% on today's $10.11. Momentum favours further upside here.
In 2033, DMII is projected to trade between $16.80 and $37.34, averaging $24.05 — a potential gain of +138% from today's $10.11. That is up +13% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Drugs Made In America Acquisition II Corp.'s 2034 outlook centres on $24.79, within a $17.04 to $39.12 range. That is up +3% on the projected 2033 average. That marks a +145% change versus current levels. Momentum favours further upside here.
By 2035, DMII could reach as high as $43.41, with a base case around $27.10 and support toward $18.33 — roughly +168% from $10.11. Buyers look set to stay in control over this stretch.
Expect DMII to range from $26.02 to $70.43 through 2040. The $41.26 average target implies a +308% move from current prices. That is up +52% on the projected 2035 average. Momentum favours further upside here.
The DMII price prediction for 2050 points to an average of $75.70 (low $42.28, high $141.69) — a potential gain of +649% on today's $10.11. Buyers look set to stay in control over this stretch.
Investing $1,000 in DMII today (≈ 98.911968 DMII) could be worth
$7,487.52
+$6,487.52 (+649%) by 2050 · US Dollar
Based on the average projected DMII price of $75.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DMIIwould be worth at today's price.
$1,000 invested in DMII on Dec 3, 2025 (≈ 101.214574 DMII) would be worth
$1,023.28
+$23.28 (+2.3%) today · 1.02× · US Dollar
Based on a DMII entry price of $9.88 vs. today's $10.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.1 | $1,000.99 | +0.1% |
| 1 month ago | $10.07 | $1,003.97 | +0.4% |
| 3 months ago | $10.02 | $1,008.98 | +0.9% |
| 6 months ago | $9.97 | $1,014.04 | +1.4% |
| All time ago | $9.88 | $1,023.28 | +2.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DMII forecast.
Our base-case forecast reaches $20.00 around 2032.
Implied market cap at $20.00: $1.27B
The multi-year forecast shows a bullish trajectory, with the average price rising to $15.70 by 2030 and to $41.25 by 2040, reaching $76.08 by 2050. The forecasted path includes 2030 min $11.58, avg $15.70, max $22.98; 2040 min $26.01, avg $41.25, max $70.44; 2050 min $42.48, avg $76.08, max $142.43. The implied ROI reaches 55.6 by 2030, 308.9 by 2040, and 654 by 2050, with sentiment remaining bullish across these years.
These are estimates, not guarantees.
Tap a question to reveal the answer.
2030 forecast: min $11.58, avg $15.70, max $22.98; ROI 55.6%; sentiment BULLISH.
Forecasts show a bullish path from 2027 onward with rising averages toward 2030–2050; however these are estimates and not guarantees.
The max forecast by 2050 is $142.43, indicating a scenario where prices could exceed $100 under the forecast assumptions.
The current price is $10.09.
The 30-day range is $10.03 to $10.15.
Drugs Made In America Acquisition II Corp. Community Discussion
0Share your Drugs Made In America Acquisition II Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.